ELI LILLY & Co (Pharmaceutical Preparations)

Pharmaceutical Preparations

Filing Clarity monitors every SEC filing for ELI LILLY & Co — Form 4 insider transactions, 8-K material events, and quarterly reports — and delivers plain-English signals with historical context.

Recent SEC filing signals

Filing Clarity delivers plain-English signals for each new filing, with historical context showing what changed from prior periods.

Earnings SynthesisELI LILLY & Co Q3-2025: "supply constraints" absent for the first time since Q1-20252026-08-17

Earnings SynthesisELI LILLY & Co Q1-2026: "transformative impact" first appearance since earnings calls began2026-08-17

Earnings SynthesisELI LILLY & Co Q2-2026: "robust demand" Consistent frequency with Q1 20262026-08-17

Ecosystem

Johnson and Johnson (competitor)Merck (competitor)Bristol Myers Squibb (competitor)Amgen (competitor)Pfizer (competitor)Novo Nordisk (competitor)

Monitor LLY with Filing Clarity

Plain-English signals for every LLY SEC filing. Free during our testing period — no credit card required.

Add LLY to my watchlist →

What is an 8-K? How to read Form 4 Pricing